133 related articles for article (PubMed ID: 7847228)
1. Valproic acid-induced hyperammonemic encephalopathy: MR appearance.
Baganz MD; Dross PE
AJNR Am J Neuroradiol; 1994 Oct; 15(9):1779-81. PubMed ID: 7847228
[No Abstract] [Full Text] [Related]
2. Valproate-induced hyperammonemic encephalopathy, rapidly improved by i.v. carnitine and glucose/thiamine.
Bøhmer T; Bøen A; Høymork SC
Scand J Gastroenterol; 2010 Jun; 45(6):762-3. PubMed ID: 20163200
[No Abstract] [Full Text] [Related]
3. Valproate-induced hyperammonemic encephalopathy.
Murphy JV
Epilepsia; 2003 Feb; 44(2):268; author reply 268. PubMed ID: 12558587
[No Abstract] [Full Text] [Related]
4. Valproic acid-induced hyperammonemic encephalopathy with triphasic waves.
Kifune A; Kubota F; Shibata N; Akata T; Kikuchi S
Epilepsia; 2000 Jul; 41(7):909-12. PubMed ID: 10897167
[TBL] [Abstract][Full Text] [Related]
5. [Metabolic encephalopathy can be a potentially life-threatening complication from valproic acid].
Meinardi MC; van den Berg GB; Groenhuijzen A; Driessen JT; Maas HA; Wolfhagen FH
Ned Tijdschr Geneeskd; 2008 Feb; 152(5):278-82. PubMed ID: 18333544
[TBL] [Abstract][Full Text] [Related]
6. Valproate-induced encephalopathy: assessment with MR imaging and 1H MR spectroscopy.
Ziyeh S; Thiel T; Spreer J; Klisch J; Schumacher M
Epilepsia; 2002 Sep; 43(9):1101-5. PubMed ID: 12199737
[TBL] [Abstract][Full Text] [Related]
7. Valproicacid-induced hyperammonemic encephalopathy in the emergency department.
Pliego Cosano R; Moreno Rosauro JM; Clavero Olmos M
Emergencias; 2019 Oct; 31(5):364-365. PubMed ID: 31625314
[No Abstract] [Full Text] [Related]
8. Different clinical manifestations of hyperammonemic encephalopathy.
Gomceli YB; Kutlu G; Cavdar L; Sanivar F; Inan LE
Epilepsy Behav; 2007 Jun; 10(4):583-7. PubMed ID: 17412645
[TBL] [Abstract][Full Text] [Related]
9. Valproate-induced hyperammonemic encephalopathy.
Chou HF; Yang RC; Chen CY; Jong YJ
Pediatr Neonatol; 2008 Oct; 49(5):201-4. PubMed ID: 19133574
[TBL] [Abstract][Full Text] [Related]
10. Hyperammonaemic encephalopathy after initiation of valproate therapy in unrecognised ornithine transcarbamylase deficiency.
Oechsner M; Steen C; Stürenburg HJ; Kohlschütter A
J Neurol Neurosurg Psychiatry; 1998 May; 64(5):680-2. PubMed ID: 9598692
[TBL] [Abstract][Full Text] [Related]
11. Valproate-induced hyperammonemic encephalopathy.
Bhatia H; Raman PG
J Assoc Physicians India; 2005 Feb; 53():158. PubMed ID: 15847043
[No Abstract] [Full Text] [Related]
12. Valproate-induced hyperammonemic encephalopathy in the presence of topiramate.
Hamer HM; Knake S; Schomburg U; Rosenow F
Neurology; 2000 Jan; 54(1):230-2. PubMed ID: 10636156
[TBL] [Abstract][Full Text] [Related]
13. [Hyperammonemic encephalopathy associated with valproate acid].
Osuna MT; Burcet J; Ramió L; Ustrell X; Silva Y; Molins A
Neurologia; 2003; 18(6):347-50. PubMed ID: 12838456
[TBL] [Abstract][Full Text] [Related]
14. Spike-wave stupor in a patient with metabolic encephalopathy.
Day B
J Clin Neurosci; 2007 Feb; 14(2):187; author reply 187. PubMed ID: 16790351
[No Abstract] [Full Text] [Related]
15. [Hyperammonemia during sodium valproate therapy: clinically relevant or accidental finding?].
Ettlin T; Scollo-Lavizzari G
Schweiz Rundsch Med Prax; 1986 Jul; 75(29):881-5. PubMed ID: 3090672
[No Abstract] [Full Text] [Related]
16. Valproic acid and zonisamide induced hyperammonemic encephalopathy.
Ilieva HS; Newman JW; Fields RK; Croom JE
Clin Neurol Neurosurg; 2020 Sep; 196():105894. PubMed ID: 32645624
[No Abstract] [Full Text] [Related]
17. [Hyperammonaemic encephalopathy due to valproic acid in the neonatal period].
Jiménez-Parrilla F; Pérez-Sánchez A; Núñez-Solís JM; Madruga-Garrido M; Losada-Martínez A
Rev Neurol; 2009 Jun 1-15; 48(11):613-4. PubMed ID: 19472163
[No Abstract] [Full Text] [Related]
18. Hippocampal involvement in valproate-induced acute hyperammonemic encephalopathy.
Soares-Fernandes JP; Machado A; Ribeiro M; Ferreira C; Figueiredo J; Rocha JF
Arch Neurol; 2006 Aug; 63(8):1202-3. PubMed ID: 16908754
[No Abstract] [Full Text] [Related]
19. Hyperaminoacidemia in epileptic children treated with valproic acid.
Castro-Gago M; Rodrigo-Saez E; Novo-Rodriguez I; Camiña MF; Rodriguez-Segade S
Childs Nerv Syst; 1990 Dec; 6(8):434-6. PubMed ID: 2095300
[TBL] [Abstract][Full Text] [Related]
20. Reversible valproic acid-induced dementia: a case report.
Zaret BS; Cohen RA
Epilepsia; 1986; 27(3):234-40. PubMed ID: 3084231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
